Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure. Census population 585,708. Maryland Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Baltimore clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Baltimore storefront.
Extracellular Matrix (ECM) Therapy in Baltimore, MD for clinics & physicians. ECM therapy products provide… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 25% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. extracellular matrix therapy inventory is national; utilization is JL-local.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Baltimore we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure.
We are not going to invent a Baltimore warehouse or a five-star local review. What you get is extracellular matrix therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JL, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 14.4% of adults — 2.4 points above the U.S. 12% figure. Obesity is 38.1%; arthritis is 25%. That is place-level BRFSS modeling, not a clinic census and not a Baltimore trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Maryland clinician.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay.
If you operate in Maryland and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Baltimore tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Baltimore, MD.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Baltimore is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Baltimore — 2.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Maryland Part B wound biologics follow this contractor (siblings: DC, DE, NJ, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Baltimore. Useful for joint-program math; still needs a diagnosis and privileging.
No Baltimore storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.